Terms: = Lung cancer AND MLLT11, Q13015, 10962, ENSG00000213190, AF1Q
3 results:
1. LPAR5 stimulates the malignant progression of non-small-cell lung carcinoma by upregulating mllt11.
Zhang HP; Chen QK; Xu JF
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8902-8910. PubMed ID: 32964980
[TBL] [Abstract] [Full Text] [Related]
2. af1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis.
Park J; Schlederer M; Schreiber M; Ice R; Merkel O; Bilban M; Hofbauer S; Kim S; Addison J; Zou J; Ji C; Bunting ST; Wang Z; Shoham M; Huang G; Bago-Horvath Z; Gibson LF; Rojanasakul Y; Remick S; Ivanov A; Pugacheva E; Bunting KD; Moriggl R; Kenner L; Tse W
Oncotarget; 2015 Aug; 6(24):20697-710. PubMed ID: 26079538
[TBL] [Abstract] [Full Text] [Related]
3. Establishment of an experimental human lung adenocarcinoma cell line SPC-A-1BM with high bone metastases potency by (99m)Tc-MDP bone scintigraphy.
Yang S; Dong Q; Yao M; Shi M; Ye J; Zhao L; Su J; Gu W; Xie W; Wang K; Du Y; Li Y; Huang Y
Nucl Med Biol; 2009 Apr; 36(3):313-21. PubMed ID: 19324277
[TBL] [Abstract] [Full Text] [Related]
